Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Mar 07, 2018
Most read this week
Urologic Oncology: Seminars and Original Investigations | Mar 07, 2018